These are access-pathway questions rather than therapeutic approval
Table 2 shows that 43.1% of participants with experience using GLP-1 drugs expected the drugs to have a significant impact on preferences and purchasing habits, compared to just 14.3% of those without experience with the drugs
Product: Hanson Pharmaceutical's GLP-1/GIP dual target weight loss innovative drug, Olepotide, has been accepted for application and marketing for weight loss indications On June 4, 2026, Hanson Pharmaceutical Group Co., Ltd
To increase the credibility of the target genes, we conducted target gene analysis on Xiaoyaokeli, another TCM that can treat dry and sparse hair, and we screened a total of 460 target genes
The conversion of reduced GSH to oxidized glutathione (GSSG) is achieved by either the conversion of free hydrogen peroxide to water or the reduction of lipid peroxides (L-OOH) to lipid hydroxyl derivatives (LOH), and both are essential for the maintenance of cellular redox homeostasis (41)